P327-0676 Screening compound: N-[2-(2-ETHYLPIPERIDINO)ETHYL]-2-METHYL-4-OXO-5-PROPYL-4,5-DIHYDROTHIENO[3,2-C]PYRIDINE-3-CARBOXAMIDE

P327-0676 Screening compound: N-[2-(2-ETHYLPIPERIDINO)ETHYL]-2-METHYL-4-OXO-5-PROPYL-4,5-DIHYDROTHIENO[3,2-C]PYRIDINE-3-CARBOXAMIDE
P327-0676 Screening compound: N-[2-(2-ETHYLPIPERIDINO)ETHYL]-2-METHYL-4-OXO-5-PROPYL-4,5-DIHYDROTHIENO[3,2-C]PYRIDINE-3-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound P327-0676
N-[2-(2-ETHYLPIPERIDINO)ETHYL]-2-METHYL-4-OXO-5-PROPYL-4,5-DIHYDROTHIENO[3,2-C]PYRIDINE-3-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P327-0676

Molecular Formula

C21H31N3O2S (C21 H31 N3 O2 S)

Compound Name

N-[2-(2-ETHYLPIPERIDINO)ETHYL]-2-METHYL-4-OXO-5-PROPYL-4,5-DIHYDROTHIENO[3,2-C]PYRIDINE-3-CARBOXAMIDE

IUPAC name

n/a

SMILES

CCCN(C=Cc1c2c(C(NCCN3C(CC)CCCC3)=O)c(C)s1)C2=O

InChI

InChI=1S/C21H31N3O2S/c1-4-11-24-13-9-17-19(21(24)26)18(15(3)27-17)20(25)22-10-14-23-12-7-6-8-16(23)5-2/h9,13,16H,4-8,10-12,14H2,1-3H3,(H,22,25)/t16-/m0/s1

InChI Key

GBAGASMLMWKKLF-INIZCTEOSA-N

MDL Number (MFCD)

MFCD29021058

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

389.56

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

2.857

Distribution Coefficient, logD

1.606

Water Solubility, LogSw

-3.08

Polar Surface Area

44.999

Acid Dissociation Constant (pKa)

12.18

Base Dissociation Constant (pKb)

8.63

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

61.90

P327-0676 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P327-0676 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P327-0676?
Check Price and Availability of P327-0676, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P327-0676 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P327-0676
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P327-0676
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P327-0676 available by request